Differential Diagnosis of Cognitive Disorders of Psychiatric or Neurodegenerative Origin

Launched by CENTRAL HOSPITAL, NANCY, FRANCE · Jun 13, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how a specific imaging test called 18F-FDG PET can help doctors understand different types of cognitive disorders, which are conditions that affect thinking, memory, and reasoning. The goal is to see if this test can improve the diagnosis and care of patients with these issues, helping them receive the right treatment.

If you or a loved one is an adult between the ages of 65 and 74 and are experiencing problems with memory or thinking, you might be eligible to participate in this study. To join, you must have had the 18F-FDG PET scan as part of your medical care. It's important to note that if you do not want your health data to be collected, you cannot participate. Those who join the study will help researchers learn more about cognitive disorders and how to manage them better in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients with cognitive impairment
• • Positron emission tomography with flurodeoxyglucose labeled with fluorine 18 carried out in the course of care
• Exclusion Criteria:
• • Patients objecting to the collection of their data